BioCentury
ARTICLE | Company News

Sanofi, Google in diabetes deal

September 1, 2015 1:31 AM UTC

Sanofi (Euronext:SAN; NYSE:SNY) and the life sciences unit of Google Inc. (NASDAQ:GOOG) partnered to develop data management tools to improve care in Type I and II diabetes. Joslin Diabetes Center of Harvard Medical School will serve as an advisor to the partners.

Google said the companies aim to improve diabetes management by developing technology that provides real-time tracking of parameters that affect glucose control. Neither Google spokesperson Jacquelyn Miller nor Sanofi spokesperson Mary Kathryn Steel would disclose any financial details or specific collaboration projects. ...